G. Salerno

Choriocarcinoma and partial hydatidiform moles

M. Seckl, E. Newlands, H. Rees, 2000, The Lancet.

Novel cross talk between MEK and S6K2 in FGF-2 induced proliferation of SCLC cells

I. Gout, O. Pardo, M. Seckl, 2001, Oncogene.

Modification of cell cycle and viability of TLX5 lymphoma in vitro by sulfoxide-ruthenium compounds and cisplatin detected by flow cytometry.

A. Bergamo, G. Sava, M. Cocchietto, 1998, Chemico-biological interactions.

Fate of the antimetastatic ruthenium complex ImH [trans-RuCl4(DMSO)Im] after acute i.v. treatment in mice.

G. Sava, E. Alessio, G. Mestroni, 2000, Anticancer research.

Fibroblast growth factor-2 induces translational regulation of Bcl-XL and Bcl-2 via a MEK-dependent pathway. CORRELATION WITH RESISTANCE TO ETOPOSIDE-INDUCED APOPTOSIS.

S. Raguz, J. Downward, O. Pardo, 2002, The Journal of Biological Chemistry.

Fibroblast Growth Factor-2 Induces Translational Regulation of Bcl-XL and Bcl-2 via a MEK-dependent Pathway

S. Raguz, J. Downward, O. Pardo, 2002, The Journal of Biological Chemistry.

Reduction of Lung Metastases by Na[trans-RuCl4(DMSO)Im] is not Coupled With the Induction of Chemical Xenogenization

A. Bergamo, G. Sava, E. Alessio, 1996, Metal-based drugs.